Published in J Stud Alcohol Drugs on July 01, 2008
The feasibility and cost of neonatal screening for prenatal alcohol exposure by measuring phosphatidylethanol in dried blood spots. Alcohol Clin Exp Res (2013) 0.90
A modified Delphi study of screening for fetal alcohol spectrum disorders in Australia. BMC Pediatr (2013) 0.88
Assessment of benefits of a universal screen for maternal alcohol use during pregnancy. Birth Defects Res A Clin Mol Teratol (2010) 0.86
Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med (2008) 7.75
Effect of a clinical pathway to reduce hospitalizations in nursing home residents with pneumonia: a randomized controlled trial. JAMA (2006) 3.83
Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP). BMJ (2011) 3.81
Cast versus splint in children with minimally angulated fractures of the distal radius: a randomized controlled trial. CMAJ (2010) 3.15
Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease. Med Decis Making (2002) 2.53
Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med (2007) 2.50
A prospective, observational registry of patients with severe sepsis: the Canadian Sepsis Treatment and Response Registry. Crit Care Med (2009) 2.17
Systematic review and meta-analysis of transurethral resection of the prostate versus minimally invasive procedures for the treatment of benign prostatic obstruction. Urology (2009) 2.05
Ontario multidetector computed tomographic coronary angiography study: field evaluation of diagnostic accuracy. Arch Intern Med (2011) 1.97
A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. CMAJ (2003) 1.93
Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). Eur J Pain (2008) 1.76
Calculating utility decrements associated with an adverse event: marginal Tobit and CLAD coefficients should be used with caution. Med Decis Making (2011) 1.67
Methodological guidance documents for evaluation of ethical considerations in health technology assessment: a systematic review. Expert Rev Pharmacoecon Outcomes Res (2014) 1.58
A nurse-coordinated model of care versus usual care for stage 3/4 chronic kidney disease in the community: a randomized controlled trial. Clin J Am Soc Nephrol (2011) 1.58
Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American Academy of Neurology. Neurology (2014) 1.54
A randomized trial of strategies for assessing eligibility for long-term domiciliary oxygen therapy. Am J Respir Crit Care Med (2005) 1.54
Coverage with evidence development: the Ontario experience. Int J Technol Assess Health Care (2011) 1.53
Pharmacologic management of neovascular age-related macular degeneration: systematic review of economic evidence and primary economic evaluation. Can J Ophthalmol (2010) 1.51
Cost analysis of multiplex PCR testing for diagnosing respiratory virus infections. J Clin Microbiol (2009) 1.51
The cost-effectiveness of extended-duration antithrombotic prophylaxis after total hip arthroplasty. J Bone Joint Surg Am (2007) 1.42
Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients. Circ Cardiovasc Qual Outcomes (2008) 1.40
The effectiveness of integrated health information technologies across the phases of medication management: a systematic review of randomized controlled trials. J Am Med Inform Assoc (2011) 1.38
Cost-effectiveness of physiologic pacing: results of the Canadian Health Economic Assessment of Physiologic Pacing. Heart Rhythm (2005) 1.38
A randomized controlled trial of laparoscopic nissen fundoplication versus proton pump inhibitors for treatment of patients with chronic gastroesophageal reflux disease: One-year follow-up. Surg Innov (2006) 1.37
Analysis of health utility data when some subjects attain the upper bound of 1: are Tobit and CLAD models appropriate? Value Health (2010) 1.32
Canadian Cardiovascular Society/Canadian Heart Rhythm Society position paper on implantable cardioverter defibrillator use in Canada. Can J Cardiol (2005) 1.25
Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another. Curr Med Res Opin (2007) 1.23
Effect of provider and patient reminders, deployment of nurse practitioners, and financial incentives on cervical and breast cancer screening rates. Can Fam Physician (2013) 1.21
Cost-effectiveness analysis of a randomized trial comparing care models for chronic kidney disease. Clin J Am Soc Nephrol (2011) 1.21
The economics of health information technology in medication management: a systematic review of economic evaluations. J Am Med Inform Assoc (2011) 1.20
A review of the cost of cardiovascular disease. Can J Cardiol (2009) 1.20
Evaluation of selection bias in an incident-based dementia autopsy case series. Alzheimer Dis Assoc Disord (2005) 1.17
Establishing a comprehensive continuum from an evidentiary base to policy development for health technologies: the Ontario experience. Int J Technol Assess Health Care (2007) 1.16
A randomized controlled trial of laparoscopic Nissen fundoplication versus proton pump inhibitors for the treatment of patients with chronic gastroesophageal reflux disease (GERD): 3-year outcomes. Surg Endosc (2011) 1.15
Cost-effectiveness of ventricular assist device therapy as a bridge to transplantation compared with nonbridged cardiac recipients. Circulation (2013) 1.15
Validation of Chinese Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) in patients scheduled for total knee replacement. Qual Life Res (2008) 1.08
Common Drug Review recommendations: an evidence base for expectations? Pharmacoeconomics (2012) 1.08
Patient views on reminder letters for influenza vaccinations in an older primary care patient population: a mixed methods study. Can J Public Health (2008) 1.06
The burden of adult obesity in Canada. Chronic Dis Can (2007) 1.05
Cost-utility analysis of radical nephrectomy versus partial nephrectomy in the management of small renal masses: Adjusting for the burden of ensuing chronic kidney disease. Can Urol Assoc J (2013) 1.05
Cardiovascular Health Awareness Program (CHAP): a community cluster-randomised trial among elderly Canadians. Prev Med (2008) 1.04
A randomized controlled study of the acute and chronic effects of cooling therapy for MS. Neurology (2003) 1.03
Persistence and adherence to cholesterol lowering agents: evidence from Régie de l'Assurance Maladie du Québec data. Am Heart J (2006) 1.00
The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women. BMC Musculoskelet Disord (2011) 0.99
Oseltamivir for treatment of influenza in healthy adults: pooled trial evidence and cost-effectiveness model for Canada. Value Health (2003) 0.99
Electronic health record use to classify patients with newly diagnosed versus preexisting type 2 diabetes: infrastructure for comparative effectiveness research and population health management. Popul Health Manag (2011) 0.98
Effects of study design and trends for EVAR versus OSR. Vasc Health Risk Manag (2008) 0.97
The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32-35 weeks: a Canadian-based analysis . Curr Med Res Opin (2008) 0.96
Health status, hospitalizations, day procedures, and physician costs associated with body mass index (BMI) levels in Ontario, Canada. Clinicoecon Outcomes Res (2012) 0.96
Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application. Clinicoecon Outcomes Res (2011) 0.95
Safety of tissue expander/implant versus autologous abdominal tissue breast reconstruction in postmastectomy breast cancer patients: a systematic review and meta-analysis. Plast Reconstr Surg (2014) 0.94
Intra-arterial thrombolysis vs. standard treatment or intravenous thrombolysis in adults with acute ischemic stroke: a systematic review and meta-analysis. Int J Stroke (2013) 0.94
Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents. Clinicoecon Outcomes Res (2012) 0.92
A review of methods used in long-term cost-effectiveness models of diabetes mellitus treatment. Pharmacoeconomics (2010) 0.92
Cost-effectiveness of alternative treatments for women with osteoporosis in Canada. Curr Med Res Opin (2006) 0.92
The cost effectiveness of palivizumab in term Inuit infants in the Eastern Canadian Arctic. J Med Econ (2009) 0.92
Enabling medication management through health information technology (Health IT). Evid Rep Technol Assess (Full Rep) (2011) 0.92
Processes, contexts, and rationale for disinvestment: a protocol for a critical interpretive synthesis. Syst Rev (2014) 0.92
Simulating an emergency department: the importance of modeling the interactions between physicians and delegates in a discrete event simulation. BMC Med Inform Decis Mak (2013) 0.91
Do canadian researchers and the lay public prioritize biomedical research outcomes equally? A choice experiment. Acad Med (2013) 0.91
Estimation of the impact of diabetes-related complications on health utilities for patients with type 2 diabetes in Ontario, Canada. Qual Life Res (2011) 0.91
Cost-effectiveness of a shared computerized decision support system for diabetes linked to electronic medical records. J Am Med Inform Assoc (2011) 0.90
Evaluation of health outcomes in osteoarthritis patients after total knee replacement: a two-year follow-up. Health Qual Life Outcomes (2010) 0.90
How to use multi-criteria decision analysis methods for reimbursement decision-making in healthcare: a step-by-step guide. Expert Rev Pharmacoecon Outcomes Res (2013) 0.90